A new dual vaccine for COVID-19 and flu shows strong immune responses and good safety in adults over 50, offering a potential ...

Poor vaccine response in dialysis was linked to heart failure and low albumin, not dialysis-specific factors, highlighting ...

Chronic heart failure and hypoalbuminaemia are linked to a poor antibody response at 3 months after the third dose of the SARS-CoV-2 mRNA vaccine in patients undergoing maintenance dialysis.

The research highlights the potential of these immune proteins to enhance the effectiveness of checkpoint inhibitors in certain individuals.

Researchers saw some cases where a patient’s own autoantibodies boosted likelihood of responding to checkpoint blockade.

GEO-MVA received favorable European regulatory guidance supporting streamlined development pathway GEO-CM04S1 demonstrates ...

Researchers describe six subsets of memory B cells — including one subset that produces the transcription factor T-bet. Using ...

Influenza hemagglutinin subunit vaccines are more effective and offer better cross protection against various influenza virus ...

Co-administration of OVX836 with seasonal inactivated influenza vaccine (Fluarix® Tetra) was well-tolerated and demonstrated a favorable safety profileRobust complementary immune responses were ...

At the surface, the immune response to a flu virus is simple. Some cells recognize the pathogen and send a signal to the immune system, and immune cells produce a potentially lifesaving antibody ...

Blue Lake Biotechnology, Inc., a clinical-stage intranasal vaccine company developing parainfluenza virus 5 (PIV5)-vectored vaccines that harness the full breadth of the immune system to protect ...